Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,874 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics of pediatric febrile urinary tract infection in Japan.
Ohnishi T, Mishima Y, Matsuda N, Sato D, Umino D, Yonezawa R, Kinoshita K, Tamura K, Mimura S, Ariji S, Maeda N, Ozaki K, Fukushima H, Arakuma T, Tsuchida S, Nishimoto H, Araki Y, Yoshida M, Tamame T, Suzuki S, Sekijima T, Kowase T, Takahashi K, Kamimaki I. Ohnishi T, et al. Among authors: yoshida m. Int J Infect Dis. 2021 Mar;104:97-101. doi: 10.1016/j.ijid.2020.12.066. Epub 2020 Dec 28. Int J Infect Dis. 2021. PMID: 33383218 Free article.
Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
Shinjoh M, Sugaya N, Furuichi M, Araki E, Maeda N, Isshiki K, Ohnishi T, Nakamura S, Yamada G, Narabayashi A, Nishida M, Taguchi N, Nakata Y, Yoshida M, Tsunematsu K, Shibata M, Munenaga T, Hirano Y, Ookawara I, Sekiguchi S, Kobayashi Y, Yamaguchi Y, Yoshida N, Mitamura K, Takahashi T; Keio Pediatric Influenza Research Group. Shinjoh M, et al. Among authors: yoshida m, yoshida n. Vaccine. 2019 Jul 9;37(30):4047-4054. doi: 10.1016/j.vaccine.2019.05.090. Epub 2019 Jun 8. Vaccine. 2019. PMID: 31186191
Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
Shinjoh M, Sugaya N, Yamaguchi Y, Ookawara I, Nakata Y, Narabayashi A, Furuichi M, Yoshida N, Kamei A, Kuramochi Y, Shibata A, Shimoyamada M, Nakazaki H, Maejima N, Yuasa E, Araki E, Maeda N, Ohnishi T, Nishida M, Taguchi N, Yoshida M, Tsunematsu K, Shibata M, Hirano Y, Sekiguchi S, Kawakami C, Mitamura K, Takahashi T. Shinjoh M, et al. Among authors: yoshida m, yoshida n. PLoS One. 2021 Mar 26;16(3):e0249005. doi: 10.1371/journal.pone.0249005. eCollection 2021. PLoS One. 2021. PMID: 33770132 Free PMC article.
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.
Shinjoh M, Furuichi M, Kobayashi H, Yamaguchi Y, Maeda N, Yaginuma M, Kobayashi K, Nogayama T, Chiga M, Oshima M, Kuramochi Y, Yamada G, Narabayashi A, Ookawara I, Nishida M, Tsunematsu K, Kamimaki I, Shimoyamada M, Yoshida M, Shibata A, Nakata Y, Taguchi N, Mitamura K, Takahashi T. Shinjoh M, et al. Among authors: yoshida m. Vaccine. 2022 May 11;40(22):3018-3026. doi: 10.1016/j.vaccine.2022.04.033. Epub 2022 Apr 11. Vaccine. 2022. PMID: 35450780 Free PMC article.
Clinical features and treatment strategies of febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a multicenter retrospective observational study in Japan.
Ohnishi T, Mishima Y, Naito T, Matsuda N, Ariji S, Umino D, Tamura K, Nishimoto H, Kinoshita K, Maeda N, Kawaguchi A, Yonezawa R, Mimura S, Fukushima H, Nanao K, Yoshida M, Sekijima T, Kamimaki I. Ohnishi T, et al. Among authors: yoshida m. Int J Infect Dis. 2022 Dec;125:97-102. doi: 10.1016/j.ijid.2022.09.033. Epub 2022 Sep 28. Int J Infect Dis. 2022. PMID: 36180033 Free article.
Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19.
Shinjoh M, Furuichi M, Tsuzuki S, Iqbal A, Fukushima N, Soen S, Fukushima H, Kobayashi K, Yamada G, Narabayashi A, Tsunematsu K, Maeda N, Shimoyamada M, Yoshida M, Kuramochi Y, Shibata A, Yamaguchi Y, Yaginuma M, Takahashi T, Ishikane M, Sugaya N; Keio Pediatric Influenza Research Group. Shinjoh M, et al. Among authors: yoshida m. Vaccine. 2023 Jul 25;41(33):4777-4781. doi: 10.1016/j.vaccine.2023.06.082. Epub 2023 Jun 30. Vaccine. 2023. PMID: 37419851 Free article.
Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.
Shinjoh M, Sugaya N, Yamaguchi Y, Tomidokoro Y, Sekiguchi S, Mitamura K, Fujino M, Shiro H, Komiyama O, Taguchi N, Nakata Y, Yoshida N, Narabayashi A, Myokai M, Sato M, Furuichi M, Baba H, Fujita H, Sato A, Ookawara I, Tsunematsu K, Yoshida M, Kono M, Tanaka F, Kawakami C, Kimiya T, Takahashi T, Iwata S; Keio Pediatric Influenza Research Group. Shinjoh M, et al. Among authors: yoshida m, yoshida n. PLoS One. 2015 Aug 28;10(8):e0136539. doi: 10.1371/journal.pone.0136539. eCollection 2015. PLoS One. 2015. PMID: 26317334 Free PMC article. Clinical Trial.
Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
Sugaya N, Shinjoh M, Kawakami C, Yamaguchi Y, Yoshida M, Baba H, Ishikawa M, Kono M, Sekiguchi S, Kimiya T, Mitamura K, Fujino M, Komiyama O, Yoshida N, Tsunematsu K, Narabayashi A, Nakata Y, Sato A, Taguchi N, Fujita H, Toki M, Myokai M, Ookawara I, Takahashi T. Sugaya N, et al. Among authors: yoshida m, yoshida n. Euro Surveill. 2016 Oct 20;21(42):30377. doi: 10.2807/1560-7917.ES.2016.21.42.30377. Euro Surveill. 2016. PMID: 27784529 Free PMC article.
10,874 results
You have reached the last available page of results. Please see the User Guide for more information.